Company Tagline
Life Science Investing
Industry Category
Business Keywords
Company Description
Abingworth is a premier transatlantic life sciences investment firm dedicated to converting pioneering science into innovative medicines. Through strategic capital and expert guidance, Abingworth empowers exceptional management teams in building world-class companies.
With a rich history dating back to 1973, Abingworth has invested in over 180 life science ventures, resulting in 46 mergers and acquisitions, and over 70 initial public offerings. Our investment approach focuses on three key areas: seed and early-stage ventures, development-stage companies, and clinical co-development initiatives. Abingworth has offices at 38 Jermyn Street, London, UK, SW1Y 6DN, GB; 3000 Sand Hill Road, B4-135, Menlo Park, CA CA 94025, US; and 420 Boylston Street, Suite 405, Boston, MA 02116, US.
Abingworth supports its portfolio companies with a team of seasoned professionals. Abingworth became part of Carlyle (NASDAQ: CG) on August 1, 2022. We invite the management team at Abingworth to further enrich our platform by creating a customized and exclusive company showcase and product listing.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
Partners in Equity
Venture-Capital-and-Private-Equity-PrincipalsPartners in Equity supports companies and funds that create solutions to environmental challenges.
Center Rock Capital Partners, LP
Venture-Capital-and-Private-Equity-PrincipalsIndustrial Middle Market Private Equity
Insight Innovation Fund
Venture-Capital-and-Private-Equity-PrincipalsNot just about investing in AI and it’s start-ups, but owning the infrastructure on which it works.
Kuo Sharper Initiative KSI
Venture-Capital-and-Private-Equity-PrincipalsKSI is an impact investment fund that supports lending to small and medium businesses in Africa and...
Alternative Company Names
This company is also known as